ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
5
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,508
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
The von Willebrand disease prophylaxis network: exploring a treatment concept.
Author(s):
E Berntorp
,
T Abshire
,
Publication date:
2006-10-31
Journal:
Journal of Thrombosis and Haemostasis
Keywords:
Age Factors
,
Coagulants
,
therapeutic use
,
Europe
,
Female
,
Hemorrhage
,
etiology
,
mortality
,
prevention & control
,
Humans
,
Male
,
United States
,
von Willebrand Diseases
,
complications
,
drug therapy
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via crossref license)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ChemSpider related publications
Author and article information
Journal
PubMed ID::
17059476
DOI::
10.1111/j.1538-7836.2006.02179.x
ScienceOpen disciplines:
Chemistry
Keywords:
Age Factors
,
Coagulants
,
therapeutic use
,
Europe
,
Female
,
Hemorrhage
,
etiology
,
mortality
,
prevention & control
,
Humans
,
Male
,
United States
,
von Willebrand Diseases
,
complications
,
drug therapy
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Age Factors
,
Coagulants
,
therapeutic use
,
Europe
,
Female
,
Hemorrhage
,
etiology
,
mortality
,
prevention & control
,
Humans
,
Male
,
United States
,
von Willebrand Diseases
,
complications
,
drug therapy
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,508
2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines
Authors:
Maha Othman
,
Emmanuel J Favaloro
An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers.
Authors:
Wenhua Zhou
,
Tung-Han Tsai
,
Eric Bouhassira
An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult.
Authors:
J Favaloro
See all similar
Cited by
5
Prophylactic management of patients with von Willebrand disease
Authors:
Massimo Franchini
,
Omid Seidizadeh
,
Pier Mannucci
Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review
Authors:
Ping Du
,
Aurore Bergamasco
,
Yola Moride
…
Current therapy in children and adolescents with von Willebrand disease
Authors:
I Buga-Corbu
,
C Arion
See all cited by